In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Wilfried Mullens
Wilfried Mullens Wilfried Mullens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

Speciality : Acute Heart Failure

40 presentations from this speaker

Cardiac remodelling in heart failure – the implications for patients.

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : W Mullens (Genk,BE)
  • Sponsorered by Novartis Pharma AG

Cardiorenal syndrome.

Event : ESC Congress 2020

  • Session : Heart Failure in the Intensive Care Unit - Essential Update
  • Speaker : W Mullens (Genk,BE)

CRT: patient selection, optimal programming and post-implantation care.

Event : ESC Congress 2020

  • Session : Interventions and Devices in Chronic Heart Failure
  • Speaker : W Mullens (Genk,BE)

Effects of Dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePublications
  • Speaker : W Mullens (Genk,BE)

Experts on the Spot: Cardiac remodelling and outcomes.

Event : HFA Discoveries 2020

  • Session : Experts on the Spot: Cardiac remodelling and outcomes
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsored by Novartis Pharma AG

How do we set up a heart team, how do we deliver the therapy to the patients.

Event : Webinar 2020

  • Session : HFA Webinars 2020
  • Speaker : W Mullens (Genk,BE), P Raake (Heidelberg,DE), R Venkateswaran (,GB)

Implementing Remote Device Therapies in the Modern Heart Failure Clinic.

Event : HFA Discoveries 2020

  • Session : Remote Management of Device Heart Failure Patients: New Paradigms for the Post-COVID-19 Era
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by Medtronic

Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsorered by Novartis Pharma AG

Which heart failure patients should receive CRT and how should they be followed?

Event : ESC Congress 2020

  • Session : Life Saving Device Therapies in Cardiology - Essential Update
  • Speaker : W Mullens (Genk,BE)

A practical approach to diuretic use in heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : K Damman (Groningen,NL), A Mebazaa (Paris,FR), W Mullens (Genk,BE)

Diuretic resistance.

Event : Heart Failure 2019

  • Session : Assessment and treatment of congestion
  • Speaker : W Mullens (Genk,BE)
  • Joint Session with Inter-American Society of Cardiology

Latest update on implantable device therapy: conclusions

Event : ESC Congress 2019

  • Session : Heart failure in 2019: latest update on implantable device therapy
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by Medtronic

My patient has advanced heart failure and cardiorenal syndrome

Event : ESC Congress 2019

  • Session : Hard to diagnose and hard to treat heart failure patients.
  • Speaker : W Mullens (Genk,BE)

Optimising the post implant care.

Event : Heart Failure 2019

  • Session : Cardiac resynchronisation therapy: optimising device use
  • Speaker : W Mullens (Genk,BE)

Pressure monitoring.

Event : Heart Failure 2019

  • Session : Parade of devices 1: attend and learn
  • Speaker : W Mullens (Genk,BE)

Programming and follow up to optimise cardiac resynchronization therapy

Event : ESC Congress 2019

  • Session : How to get the most out of cardiac resynchronisation therapy?
  • Speaker : W Mullens (Genk,BE)

Summary and conclusions - An update on device technologies in heart failure.

Event : Heart Failure 2019

  • Session : An update on device technologies in heart failure
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by Medtronic

The road ahead in acute heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : O Chioncel (Bucuresti,RO), A Mebazaa (Paris,FR), W Mullens (Genk,BE)

Update on devices from HFA workshop 2019

Event : Heart Failure 2019

  • Session : Heart failure innovation - Drugs, devices, artificial intelligence
  • Speaker : W Mullens (Genk,BE)
  • Joint session with Heart failure Association of India

Are natriuresis, sodium and diuretics really the good, the bad and the ugly?

Event : Heart Failure 2018

  • Session : Strategies to overcome diuretic resistance
  • Speaker : W Mullens (Genk,BE)

Beyond CRT - When should I consider alternatives to CRT?

Event : Heart Failure 2018

  • Session : Role of device in heart failure guidelines
  • Speaker : W Mullens (Genk,BE)
  • Joint session with the Chinese Heart Failure Association and the Korean Heart Failure Society

Devices

Event : Heart Failure 2018

  • Session : HFpEF - The new HFA consensus
  • Speaker : W Mullens (Genk,BE)

Optimising CRT during follow-up

Event : EHRA 2018

  • Session : Cardiac Resynchronisation Therapy in 2018 (CRT)
  • Speaker : W Mullens (Genk,BE)

Sodium and water retention in heart failure: mechanisms and current treatment strategies.

Event : Heart Failure 2018

  • Session : Problems and optimization of volume management in patients with acute heart failure
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by RenalGuard

Strategies to enhance response to CRT

Event : Heart Failure 2018

  • Session : Clinical dilemmas in cardiac device therapy
  • Speaker : W Mullens (Genk,BE)
  • Joint session with the European Heart Rhythm Association

When should I consider alternatives to CRT

Event : EHRA 2018

  • Session : Beyond CRT - Device therapy in advanced heart failure
  • Speaker : W Mullens (Genk,BE)

Cardiac resynchronization therapy: getting the best out of the machine!

Event : Heart Failure 2017

  • Session : Beat as one: a multidisciplinary approach to treating heart failure
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by St. Jude Medical in now Abbott

Decongestive therapies.

Event : Heart Failure 2017

  • Session : How to tackle congestion
  • Speaker : W Mullens (Genk,BE)

Diuretics.

Event : Heart Failure 2017

  • Session : Therapy of acute heart failure
  • Speaker : W Mullens (Genk,BE)

How to perform the follow-up?

Event : EuroEcho 2017

  • Session : Cardiac resynchronization therapy: how to get the best out of the device
  • Speaker : W Mullens (Genk,BE)

CRT-D vs CRT-P

Event : Heart Failure 2016

  • Session : ICD therapy in heart failure
  • Speaker : W Mullens (Genk,BE)

How to decongest medically?

Event : Heart Failure 2016

  • Session : How to tackle congestion in heart failure
  • Speaker : W Mullens (Genk,BE)

How to embed device technology in clinical practice to improve response to cardiac resynchronisation therapy.

Event : Heart Failure 2016

  • Session : Latest developments in cardiac resynchronisation therapy
  • Speaker : W Mullens (Genk,BE)
  • Sponsored by Medtronic

Kidney: angel or villain.

Event : Heart Failure 2016

  • Session : Does heart failure start with the kidney?
  • Speaker : W Mullens (Genk,BE)

Role of echocardiography in Cardiac Resynchronisation Therapy: from guidelines to real word.

Event : EuroEcho 2016

  • Session : Should I stay or should I go: imaging for cardiac resynchronisation therapy candidates
  • Speaker : W Mullens (Genk,BE)

CRT therapy in patients with < 130 ms widths is hazardous - Contra.

Event : EHRA 2015

  • Session : Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
  • Speaker : W Mullens (Genk,BE)

CRT therapy in patients with < 130 ms widths is hazardous - Rebuttal Contra.

Event : EHRA 2015

  • Session : Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
  • Speaker : W Mullens (Genk,BE)

Do we have enough evidence for CRT in QRS 120-150 ms?

Event : Heart Failure 2015

  • Session : Challenges and controversies in device therapy
  • Speaker : W Mullens (Genk,BE)

New insights into the pathophysiology.

Event : ESC Congress 2014

  • Session : Acute cardiorenal syndrome in tomorrow's world
  • Speaker : W Mullens (Genk,BE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are